|
|
granzyme mediated apoptotic signaling pathway
|
GO:0008626 |
1 |
0.478
|
Mouse |
|
|
regulation of angiotensin metabolic process
|
GO:0060177 |
4 |
0.321
|
Mouse |
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.302
|
|
|
|
neutrophil mediated killing of gram positive bacterium
|
GO:0070946 |
2 |
0.242
|
Mouse |
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.241
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.225
|
Mouse |
|
|
regulation of angiotensin levels in blood
|
GO:0002002 |
4 |
0.204
|
Mouse |
|
|
neural tube development
|
GO:0021915 |
160 |
0.201
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.195
|
Mouse |
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.176
|
|
|
|
disruption of cells of other organism involved in symbiotic interaction
|
GO:0051818 |
13 |
0.165
|
Mouse |
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.165
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.158
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.151
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.147
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.140
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.133
|
Mouse |
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.133
|
Mouse |
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.128
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.127
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.121
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.114
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.109
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.107
|
Mouse |
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.105
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.102
|
|
|
|
leukocyte mediated cytotoxicity
|
GO:0001909 |
62 |
0.100
|
Mouse |
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.097
|
Mouse |
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.096
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.095
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
83 |
0.093
|
Mouse |
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.091
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.090
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.089
|
Mouse |
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.087
|
|
|
|
disruption by host of symbiont cells
|
GO:0051852 |
11 |
0.086
|
Mouse |
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.084
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.082
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.079
|
|
|
|
t cell mediated cytotoxicity
|
GO:0001913 |
26 |
0.078
|
Mouse |
|
|
interaction with symbiont
|
GO:0051702 |
14 |
0.077
|
Mouse |
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.075
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.075
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.074
|
|
|
|
t cell mediated immunity
|
GO:0002456 |
50 |
0.074
|
Mouse |
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.074
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.073
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.072
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.072
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.072
|
|
|
|
killing by host of symbiont cells
|
GO:0051873 |
11 |
0.071
|
Mouse |
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.070
|
Mouse |
|
|
angiogenesis
|
GO:0001525 |
201 |
0.069
|
|
|
|
endochondral bone morphogenesis
|
GO:0060350 |
50 |
0.069
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.067
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.067
|
|
|
|
negative regulation of endothelial cell migration
|
GO:0010596 |
4 |
0.067
|
|
|
|
neutrophil mediated cytotoxicity
|
GO:0070942 |
8 |
0.066
|
Mouse |
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.065
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.064
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.063
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.063
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.062
|
|
|
|
defense response to gram positive bacterium
|
GO:0050830 |
50 |
0.061
|
Mouse |
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.060
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.059
|
|
|
|
killing of cells in other organism involved in symbiotic interaction
|
GO:0051883 |
13 |
0.059
|
Mouse |
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.059
|
|
|
|
neutrophil mediated killing of symbiont cell
|
GO:0070943 |
8 |
0.058
|
Mouse |
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.057
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.057
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.056
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.056
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.056
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.056
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.056
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.056
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.055
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.055
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.055
|
|
|
|
odontogenesis
|
GO:0042476 |
78 |
0.055
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.055
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.054
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.054
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.054
|
|
|
|
regulation of symbiosis encompassing mutualism through parasitism
|
GO:0043903 |
52 |
0.053
|
Mouse |
|
|
skin development
|
GO:0043588 |
220 |
0.053
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.053
|
|
|
|
regulation of systemic arterial blood pressure mediated by a chemical signal
|
GO:0003044 |
33 |
0.051
|
Mouse |
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.049
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.048
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.048
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.048
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.048
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.048
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.048
|
|
|
|
tendon formation
|
GO:0035992 |
4 |
0.048
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.047
|
|
|
|
negative regulation of lymphocyte activation
|
GO:0051250 |
91 |
0.046
|
|
|
|
myotube cell development
|
GO:0014904 |
60 |
0.046
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.046
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.045
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.045
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.045
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.045
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.045
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.045
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.045
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.044
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.044
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.044
|
|
|
|
axis elongation involved in somitogenesis
|
GO:0090245 |
4 |
0.043
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.043
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.043
|
|
|
|
negative regulation of prostatic bud formation
|
GO:0060686 |
4 |
0.042
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.042
|
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
53 |
0.042
|
|
|
|
cell killing
|
GO:0001906 |
67 |
0.042
|
Mouse |
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.042
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.042
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.041
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.041
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.041
|
|
|
|
positive regulation of b cell activation
|
GO:0050871 |
49 |
0.041
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.040
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.040
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.040
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.040
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.040
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.039
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.039
|
|
|
|
positive regulation of leukocyte mediated immunity
|
GO:0002705 |
70 |
0.039
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
83 |
0.039
|
Mouse |
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.039
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.039
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.038
|
|
|
|
cellular response to steroid hormone stimulus
|
GO:0071383 |
33 |
0.038
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.038
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.038
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.038
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.038
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.038
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.038
|
Mouse |
|
|
connective tissue development
|
GO:0061448 |
179 |
0.038
|
|
|
|
modification of morphology or physiology of other organism
|
GO:0035821 |
18 |
0.037
|
Mouse |
|
|
stem cell development
|
GO:0048864 |
219 |
0.037
|
|
|
|
somite development
|
GO:0061053 |
81 |
0.037
|
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.037
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.037
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.037
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.037
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.037
|
|
|
|
defense response to fungus
|
GO:0050832 |
12 |
0.036
|
Mouse |
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.036
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
88 |
0.036
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.036
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.035
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.035
|
|
|
|
cerebellum development
|
GO:0021549 |
77 |
0.035
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.035
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.035
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.035
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.035
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.035
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.034
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.034
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.034
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.034
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.034
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.034
|
|
|
|
defense response to gram negative bacterium
|
GO:0050829 |
28 |
0.034
|
|
|
|
limbic system development
|
GO:0021761 |
72 |
0.034
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.033
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.033
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.033
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.033
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.033
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.033
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.032
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.032
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.032
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.032
|
|
|
|
spinal cord development
|
GO:0021510 |
81 |
0.032
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.031
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.031
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.031
|
|
|
|
negative regulation of neuron projection regeneration
|
GO:0070571 |
3 |
0.031
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.031
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.031
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.031
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.031
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.031
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.031
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.031
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.030
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.030
|
Mouse |
|
|
hindbrain development
|
GO:0030902 |
128 |
0.030
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.030
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.030
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.030
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.030
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.030
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.030
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.030
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.030
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.030
|
Mouse |
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.030
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.030
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.029
|
|
|
|
negative regulation of multi organism process
|
GO:0043901 |
68 |
0.029
|
Mouse |
|
|
odontogenesis of dentin containing tooth
|
GO:0042475 |
66 |
0.029
|
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.029
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.029
|
|
|
|
metencephalon development
|
GO:0022037 |
89 |
0.028
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.028
|
|
|
|
head morphogenesis
|
GO:0060323 |
34 |
0.028
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.028
|
Mouse |
|
|
negative regulation of muscle cell differentiation
|
GO:0051148 |
33 |
0.028
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.028
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.028
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.028
|
|
|
|
regulation of cartilage development
|
GO:0061035 |
44 |
0.028
|
|
|
|
positive regulation of neural precursor cell proliferation
|
GO:2000179 |
42 |
0.028
|
|
|
|
neutrophil mediated killing of bacterium
|
GO:0070944 |
6 |
0.028
|
Mouse |
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.028
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.028
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.027
|
|
|
|
central nervous system neuron development
|
GO:0021954 |
67 |
0.027
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.027
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.027
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.027
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.027
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.027
|
|
|
|
negative regulation of blood vessel endothelial cell migration
|
GO:0043537 |
3 |
0.026
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.026
|
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.026
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.026
|
|
|
|
killing of cells of other organism
|
GO:0031640 |
13 |
0.026
|
Mouse |
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.026
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.025
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.025
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.025
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.025
|
|
|
|
positive regulation of stem cell proliferation
|
GO:2000648 |
59 |
0.025
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.025
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.025
|
|
|
|
positive regulation of keratinocyte proliferation
|
GO:0010838 |
4 |
0.025
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
70 |
0.025
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.025
|
|
|
|
regulation of lymphocyte mediated immunity
|
GO:0002706 |
84 |
0.025
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.025
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.025
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
85 |
0.025
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.025
|
|
|
|
negative regulation of secretion
|
GO:0051048 |
61 |
0.025
|
|
|
|
modification of morphology or physiology of other organism involved in symbiotic interaction
|
GO:0051817 |
16 |
0.025
|
Mouse |
|
|
cell maturation
|
GO:0048469 |
127 |
0.024
|
|
|
|
neurotransmitter secretion
|
GO:0007269 |
62 |
0.024
|
|
|
|
regulation of b cell activation
|
GO:0050864 |
81 |
0.024
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.024
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.024
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.024
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.024
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.024
|
|
|
|
neurotransmitter transport
|
GO:0006836 |
76 |
0.024
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.024
|
|
|
|
morphogenesis of a polarized epithelium
|
GO:0001738 |
37 |
0.024
|
|
|
|
nephrogenic mesenchyme development
|
GO:0072076 |
3 |
0.023
|
|
|
|
regulation of cell division
|
GO:0051302 |
76 |
0.023
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.023
|
Mouse |
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.023
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.023
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.023
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.023
|
|
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
104 |
0.023
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.023
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.023
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.023
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.023
|
|
|
|
alpha beta t cell differentiation
|
GO:0046632 |
69 |
0.023
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.023
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.023
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.022
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.022
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.022
|
|
|
|
cell fate specification
|
GO:0001708 |
72 |
0.022
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.022
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.022
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.022
|
|
|
|
regulation of neurotransmitter levels
|
GO:0001505 |
87 |
0.022
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.022
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.022
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.022
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.022
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.022
|
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.022
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.022
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.022
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.022
|
|
|
|
lymphocyte activation involved in immune response
|
GO:0002285 |
93 |
0.022
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.021
|
|
|
|
growth of symbiont involved in interaction with host
|
GO:0044116 |
23 |
0.021
|
Mouse |
|
|
neural tube closure
|
GO:0001843 |
90 |
0.021
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.021
|
|
|
|
t cell activation involved in immune response
|
GO:0002286 |
43 |
0.021
|
|
|
|
regulation of myelination
|
GO:0031641 |
20 |
0.021
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.021
|
|
|
|
positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:2000802 |
1 |
0.021
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.021
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.021
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.021
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.021
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.021
|
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.021
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.021
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.021
|
|
|
|
response to hypoxia
|
GO:0001666 |
58 |
0.021
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.021
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.021
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.021
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.020
|
|
|
|
regulation of growth of symbiont in host
|
GO:0044126 |
19 |
0.020
|
Mouse |
|
|
positive regulation of b cell proliferation
|
GO:0030890 |
24 |
0.020
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.020
|
|
|
|
regulation of glucose metabolic process
|
GO:0010906 |
60 |
0.020
|
|
|
|
hippocampus development
|
GO:0021766 |
52 |
0.020
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.020
|
|
|
|
myeloid leukocyte mediated immunity
|
GO:0002444 |
42 |
0.020
|
Mouse |
|
|
neuron death
|
GO:0070997 |
154 |
0.020
|
|
|
|
bone mineralization
|
GO:0030282 |
54 |
0.020
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
56 |
0.020
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.020
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.020
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.020
|
|
|
|
trunk segmentation
|
GO:0035290 |
4 |
0.020
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.020
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.020
|
|
|
|
learning
|
GO:0007612 |
98 |
0.020
|
|
|
|
disruption of cells of other organism
|
GO:0044364 |
13 |
0.019
|
Mouse |
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.019
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.019
|
|
|
|
cellular amino acid catabolic process
|
GO:0009063 |
25 |
0.019
|
|
|
|
sprouting angiogenesis
|
GO:0002040 |
26 |
0.019
|
|
|
|
cardiac right atrium morphogenesis
|
GO:0003213 |
3 |
0.019
|
|
|
|
positive regulation of leukocyte proliferation
|
GO:0070665 |
73 |
0.019
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.019
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
68 |
0.019
|
|
|
|
zymogen activation
|
GO:0031638 |
41 |
0.019
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.019
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.019
|
|
|
|
myoblast differentiation
|
GO:0045445 |
52 |
0.019
|
|
|
|
regulation of microvillus organization
|
GO:0032530 |
3 |
0.019
|
|
|
|
regulation of tumor necrosis factor superfamily cytokine production
|
GO:1903555 |
50 |
0.019
|
|
|
|
negative regulation of vasculature development
|
GO:1901343 |
26 |
0.019
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.019
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.019
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.019
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.019
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.018
|
|
|
|
cardiac ventricle morphogenesis
|
GO:0003208 |
50 |
0.018
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.018
|
|
|
|
regulation of t cell proliferation
|
GO:0042129 |
92 |
0.018
|
|
|
|
cell proliferation involved in outflow tract morphogenesis
|
GO:0061325 |
4 |
0.018
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.018
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.018
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.018
|
|
|
|
cardiac right ventricle formation
|
GO:0003219 |
3 |
0.018
|
|
|
|
ovulation cycle
|
GO:0042698 |
59 |
0.018
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.018
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.018
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.018
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.018
|
|
|
|
forelimb morphogenesis
|
GO:0035136 |
40 |
0.018
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.018
|
|
|
|
diencephalon development
|
GO:0021536 |
63 |
0.018
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.018
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.018
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.018
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.018
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.018
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.017
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.017
|
|
|
|
regulation of systemic arterial blood pressure by renin angiotensin
|
GO:0003081 |
20 |
0.017
|
Mouse |
|
|
cerebellar cortex development
|
GO:0021695 |
48 |
0.017
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.017
|
|
|
|
somatic stem cell maintenance
|
GO:0035019 |
47 |
0.017
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.017
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.017
|
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.017
|
|
|
|
replacement ossification
|
GO:0036075 |
26 |
0.017
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.017
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.017
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.017
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.017
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.017
|
|
|
|
embryonic digit morphogenesis
|
GO:0042733 |
56 |
0.017
|
|
|
|
negative regulation of angiogenesis
|
GO:0016525 |
25 |
0.017
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.017
|
|
|
|
binding of sperm to zona pellucida
|
GO:0007339 |
34 |
0.017
|
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
78 |
0.017
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.017
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.017
|
|
|
|
single fertilization
|
GO:0007338 |
82 |
0.016
|
|
|
|
growth of symbiont in host
|
GO:0044117 |
23 |
0.016
|
Mouse |
|
|
molting cycle
|
GO:0042303 |
90 |
0.016
|
|
|
|
regulation of myoblast differentiation
|
GO:0045661 |
29 |
0.016
|
|
|
|
nephron morphogenesis
|
GO:0072028 |
69 |
0.016
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.016
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.016
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.016
|
|
|
|
protein kinase b signaling
|
GO:0043491 |
74 |
0.016
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.016
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.016
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.016
|
|
|
|
cell differentiation involved in embryonic placenta development
|
GO:0060706 |
26 |
0.016
|
|
|
|
neutrophil mediated immunity
|
GO:0002446 |
19 |
0.016
|
Mouse |
|
|
tendon cell differentiation
|
GO:0035990 |
4 |
0.016
|
|
|
|
regulation of myeloid leukocyte differentiation
|
GO:0002761 |
58 |
0.016
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.016
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.016
|
|
|
|
endothelial cell migration
|
GO:0043542 |
44 |
0.016
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.016
|
|
|
|
oviduct development
|
GO:0060066 |
3 |
0.016
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.016
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.016
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.016
|
|
|
|
regulation of mast cell differentiation
|
GO:0060375 |
3 |
0.015
|
|
|
|
cholesterol metabolic process
|
GO:0008203 |
56 |
0.015
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.015
|
|
|
|
canonical wnt signaling pathway involved in regulation of cell proliferation
|
GO:0044340 |
3 |
0.015
|
|
|
|
positive regulation of lymphocyte mediated immunity
|
GO:0002708 |
62 |
0.015
|
|
|
|
vasodilation
|
GO:0042311 |
28 |
0.015
|
|
|
|
cd4 positive alpha beta t cell differentiation involved in immune response
|
GO:0002294 |
28 |
0.015
|
|
|
|
modification by host of symbiont morphology or physiology
|
GO:0051851 |
12 |
0.015
|
Mouse |
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.015
|
|
|
|
neurological system process involved in regulation of systemic arterial blood pressure
|
GO:0001976 |
18 |
0.015
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.015
|
|
|
|
non canonical wnt signaling pathway involved in heart development
|
GO:0061341 |
3 |
0.015
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.015
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.015
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.015
|
|
|
|
cytokine metabolic process
|
GO:0042107 |
71 |
0.015
|
|
|
|
carnitine transmembrane transport
|
GO:1902603 |
3 |
0.015
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.015
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.015
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.015
|
|
|
|
inner ear receptor cell differentiation
|
GO:0060113 |
61 |
0.015
|
|
|
|
forebrain generation of neurons
|
GO:0021872 |
63 |
0.015
|
|
|
|
androgen biosynthetic process
|
GO:0006702 |
4 |
0.015
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.015
|
|
|
|
anatomical structure maturation
|
GO:0071695 |
49 |
0.015
|
|
|
|
sperm egg recognition
|
GO:0035036 |
37 |
0.015
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
70 |
0.015
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.015
|
|
|
|
regulation of t helper 2 cell cytokine production
|
GO:2000551 |
3 |
0.015
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.015
|
|
|
|
multicellular organismal response to stress
|
GO:0033555 |
62 |
0.015
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.015
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.015
|
|
|
|
negative regulation of cell projection organization
|
GO:0031345 |
56 |
0.014
|
|
|
|
jak stat cascade
|
GO:0007259 |
42 |
0.014
|
|
|
|
regulation of carbohydrate metabolic process
|
GO:0006109 |
75 |
0.014
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.014
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.014
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.014
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.014
|
|
|
|
regulation of b cell proliferation
|
GO:0030888 |
39 |
0.014
|
|
|
|
cd4 positive alpha beta t cell activation
|
GO:0035710 |
45 |
0.014
|
|
|
|
mesenchyme morphogenesis
|
GO:0072132 |
32 |
0.014
|
|
|
|
olfactory learning
|
GO:0008355 |
2 |
0.014
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.014
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.014
|
|
|
|
mesoderm morphogenesis
|
GO:0048332 |
64 |
0.014
|
|
|
|
t helper 2 cell cytokine production
|
GO:0035745 |
4 |
0.014
|
|
|
|
tumor necrosis factor superfamily cytokine production
|
GO:0071706 |
51 |
0.014
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.014
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.014
|
|
|
|
negative regulation of lymphocyte differentiation
|
GO:0045620 |
32 |
0.014
|
|
|
|
regulation of epithelial cell migration
|
GO:0010632 |
35 |
0.014
|
|
|
|
positive regulation of neuroblast proliferation
|
GO:0002052 |
19 |
0.014
|
|
|
|
planar cell polarity pathway involved in outflow tract morphogenesis
|
GO:0061347 |
2 |
0.014
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.014
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.014
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.014
|
|
|
|
polarity specification of proximal distal axis
|
GO:0010085 |
2 |
0.014
|
|
|
|
keratinocyte proliferation
|
GO:0043616 |
21 |
0.014
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.014
|
|
|
|
myelination
|
GO:0042552 |
74 |
0.014
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.014
|
|
|
|
natural killer cell activation
|
GO:0030101 |
44 |
0.014
|
|
|
|
tissue kallikrein kinin cascade
|
GO:0002255 |
1 |
0.014
|
|
|
|
negative regulation of growth of symbiont involved in interaction with host
|
GO:0044146 |
19 |
0.014
|
Mouse |
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.014
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.014
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.014
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.014
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.014
|
|
|
|
genitalia development
|
GO:0048806 |
37 |
0.014
|
|
